Impella CP Introducer

K192769 · Abiomed, Inc. · DYB · Nov 18, 2019 · Cardiovascular

Device Facts

• Record ID: K192769
• Device Name: Impella CP Introducer
• Applicant: Abiomed, Inc.
• Product Code: DYB · Cardiovascular
• Decision Date: Nov 18, 2019
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.1340
• Device Class: Class 2

Intended Use

The Impella CP Introducer is intended for introduction of pacing leads and catheters into the bodv.

Device Story

The Impella CP Introducer is a sterile kit containing an introducer sheath (with sideport tubing, stopcock, and hemostasis valve assembly), dilators, and a guidewire. It is used by clinicians to facilitate the percutaneous introduction of pacing leads or catheters into the patient's body. The device is identical to the predicate Oscor Adelante-S2 Introducer.

Clinical Evidence

No clinical data; bench testing not required as the device is identical to the predicate.

Technological Characteristics

Sterile kit including introducer sheath, sideport tubing, stopcock, hemostasis valve assembly, dilators, and guidewire. Identical to predicate device (K122084).

Indications for Use

Indicated for the introduction of pacing leads or catheters into the body.

Regulatory Classification

Identification

A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.

Predicate Devices

• Oscor Introducer set, Model Adelante-S2 Introducer (K122084)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains two logos. On the left is the Department of Health & Human Services USA logo. On the right is the FDA U.S. Food & Drug Administration logo. The FDA logo is in blue.

November 18, 2019

Abiomed, Inc. Robert Stewart Regulatory Affairs Manager 22 Cherry Hill Drive Danvers, Massachusetts 01923

Re: K192769

Trade/Device Name: Impella CP Introducer Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: Class II Product Code: DYB Dated: September 30, 2019 Received: September 30, 2019

Dear Robert Stewart:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for

{1}------------------------------------------------

devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

for

Jessica Paulsen Director Cardiac Electrophysiology, Diagnostics, & Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K192769

Device Name Impella CP Introducer

Indications for Use (Describe)

The Impella CP Introducer is intended for introduction of pacing leads or catheters into the body.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# Impella CP Introducer 510(k) Summary

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the Safe Medical Devices Act (SMDA) of 1990 and Title 21 of the Code of Federal Regulations, Part 807.92.

## A. Application Information:

| Date Prepared: | September 27, 2019 |
|-----------------------------|------------------------------------------------------------------------------------------------------------------|
| Submitter's Name & Address: | ABIOMED, Inc.<br>22 Cherry Hill Drive<br>Danvers, MA 01923 |
| Contact Person: | J. Kenneth Ryder<br>Senior Director, Global Regulatory Affairs<br>Ph: 978-646-1707<br>E-mail: [e-mail] |
| B. Device Information: | |

#### Trade or Proprietary Name: Impella CP Introducer Common or Usual Name: Introducer, Catheter FDA Classification: Class II, DYB, 21 CFR- 870.1340 Requlation Description: Catheter Introducer Performance standards do not currently exist for these devices. Performance Standard: (i.e. none established under section 514 of the F D & C Act.)

## C. Predicate Device:

Oscor Introducer set, Model Adelante-S2 Introducer, K122084

#### D. Device Description:

The Impella CP Introducer is packaged as a sterile kit. which includes an introducer sheath (consisting of sheath with sideport tubing, stopcock and hemostasis valve assembly), and dilators, and a guidewire. It is identical to the commercially available predicate device, Oscor Introducer set, Model Adelante-S2 Introducer (cleared under K122084).

## E. Intended Use:

The Impella CP Introducer is intended for introduction of pacing leads and catheters into the bodv.

## F. Comparison of Required Technological Characteristics:

All technological characteristics of the Impella CP Introducer are identical to its commercially available predicate, including its design, packaging, manufacturing, sterilization, and labeling.

## G. Comparison to Predicate Device:

The Impella CP Introducer is identical to its commercially available predicate device.

## H. Qualification Testing:

Since the Impella CP Introducer is identical to its commercially available predicate device, no additional qualification testing was required for the substantial equivalence determination.